Dolor - Evaluación del potencial papel terapéutico de la inhibición de RANK en modelos optimizados de dolor e infertilidad asociados a endometriosis

Lab / animal OA: green CC0
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This study evaluated the therapeutic potential of RANK inhibition in mouse models of endometriosis-associated pain, using quantitative behavioral tests to measure unevoked pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text ⓘ

The paper evaluated the therapeutic potential of inhibiting RANK in optimized mouse models of endometriosis-associated pain and infertility, using quantitative behavioral tests that measured distance and time in Von Freyim, Balb-C, and CB57 strains. The study’s key findings (as reported in the paper’s available materials) addressed how RANK inhibition performed across these pain and reproductive-related endpoints. A major caveat is the reliance on specific animal model strains and behavioral paradigms as the basis for interpreting pain and infertility outcomes. This paper is centrally about endometriosis — it tests RANK inhibition in endometriosis-associated models of pain and infertility.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Dolor no evocado mediante test compartamentales cuantitativos de distancia y tiempo en modelo animal de ratón Von Freim, Balb-C y CB57 con endometriosis
Full text 1,401 characters · extracted from oa-doi-fallback · click to expand
Published March 31, 2025 | Version 1 Dataset Open Dolor - Evaluación del potencial papel terapéutico de la inhibición de RANK en modelos optimizados de dolor e infertilidad asociados a endometriosis Description Dolor no evocado mediante test compartamentales cuantitativos de distancia y tiempo en modelo animal de ratón Von Freim, Balb-C y CB57 con endometriosis Files Readme.txt Files (4.6 MB) | Name | Size | Download all | |---|---|---| | md5:7fc46ce94f91400750c43778f89592b5 | 1.6 MB | Download | | md5:fe6bb829ac490b7c7635d418595b9cc3 | 1.1 MB | Download | | md5:1ca8819f0594c0533a7a8868f6080667 | 2.3 kB | Preview Download | | md5:966c5c0628470738e3c717cd629bf3c8 | 282.6 kB | Download | | md5:59b35597587808f4c5de1c7ad91bc5f0 | 298.5 kB | Download | | md5:89f676f2570eecaee9c9d1bc5b675389 | 285.2 kB | Download | | md5:f5c13bfee1db4d56b13b8ad4b62facd7 | 199.7 kB | Download | | md5:5593785bc6a20a855bb845cd63f96236 | 206.8 kB | Download | | md5:bbef81845b63c3740b62792e010482ad | 282.6 kB | Download | | md5:7bac21df6f56c3815d88e40a8c35adcf | 304.1 kB | Download | Additional details Identifiers Funding - Instituto de Salud Carlos III - Evaluación del potencial papel terapéutico de la inhibición de RANK en modelos optimizados de dolor e infertilidad asociados a endometriosis PI20/01835 Dates - Created - 2021-01-01Start of experimental phase - Created - 2024-12-31End of experimental phase

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T10:41:45.330896+00:00
License: CC0 · commercial use OK